The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy.

The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy. - The analysis of new parameters in serum samples of UC patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031289

Enrollment

Registered

2018-02-13

Start date

2018-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have received complete information about the study and are willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1:Inability or unwillingness of patients to give written informed consent 2:Judged unsuitable for this study by the physician

Design outcomes

Primary

Measure	Time frame
1:Try to identify molecules that could correlate with endoscopic findings(UC-EIS) before treatment and at 10 weeks on therapy. 2:To test whether a novel biomarker could be used to predict mucosal healing at 1 year after treatment initiation.	—

Secondary

Measure	Time frame
1:To evaluate the correlation between the new biomarker(s) and UCDAI score at 1,4,10 weeks and 1year after treatment. 2:To evaluate the correlation between the new biomarker(s) and Matts grade at 10 weeks after treatment.	—

Countries

Japan

Contacts

Public ContactAkiko Toshimori

Showa University Koto Toyosu Hospital Digestive Disease Center

akikotoshimori@med.showa-u.ac.jp03-6204-6000

Outcome results